Browsing by Subject "miR-1013p"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Publication
    Open Access
    MiR-101-3p targets KPNA2 to inhibit the progression of lung squamous cell carcinoma cell lines
    (Universidad de Murcia, Departamento de Biologia Celular e Histiologia, 2023) Dong, Liangliang; Jiang, Hanliang; Qiu, Ting; Xu, Yiming; Chen, Enguo; Huang, Aihua; Ying, Kejing
    We herein discuss the impacts of miR-101-3p on the tumorigenesis-related cell behaviors in lung squamous cell carcinoma (LUSC) by repressing KPNA2. TCGA database was utilized to measure miR101-3p and KPNA2 levels in LUSC tissues and cells. The interaction of miR-101-3p and KPNA2-3’UTR was determined by dual luciferase assay. Western blot evaluated the protein level of KPNA2. MiR-101-3p was under-expressed in LUSC cells while KPNA2 was overexpressed. Western blot confirmed the impact of KPNA2 expression on cancer cell progression. The negative regulatory impact of miR-101-3p on KPNA2 was also verified. In vitro cell function assays revealed the suppressing effect of high miR-101-3p expression on cell invasion, migration and viability, as well as its promoting effect on apoptosis. Up-regulated miR-101-3p weakened the promoting effect of overexpressed KPNA2 on LUSC malignant progression. To conclude, miR-101-3p repressed viability, invasion, and migration, and facilitated cell apoptosis in LUSC by suppressing KPNA2.